KIMIA BIOSCIENCES LIMITED Share Price

KIMIA BIOSCIENCES LIMITED Share Price

BSE: 530313
|
Pharmaceuticals
|
S Cap
₹ 27.24
-₹2.28 (-7.72%)
1D
Last updated 11 Sep, 2026, 15:24 IST

KIMIA BIOSCIENCES LIMITED Share Price Today

As of 15 Sep 2026, KIMIA BIOSCIENCES LIMITED share price is ₹27.24. The stock opened at ₹30.00, compared to its previous close of ₹29.52. During today's trading session, KIMIA BIOSCIENCES LIMITED share price moved in the range of ₹25.51 to ₹30.00, with an average price of ₹27.76 for the day. Looking at its last 52-week, the stock has touched a low of ₹23.20 and a high of ₹43.28.

₹25.51
7.72% down today
₹30.00
1D LOW
1D HIGH

KIMIA BIOSCIENCES LIMITED Returns Calculator

Circuit
L
H
₹22.09
₹33.13
52-week
L
H
₹23.20
₹43.28

About KIMIA BIOSCIENCES LIMITED

KIMIA BIOSCIENCES LIMITED Share Price
ISIN
INE285U01025
Sector Market Cap
₹ 130.63 Cr

Kimia Biosciences Limited is an India-based company, which is engaged in the manufacturing of bulk drugs addressing various high-potential therapeutic segments. The Company provides its products under various categories: Commercial Active Pharmaceutical Ingredients (APIs), and Commercial KSMs, Intermediates and Reagents. The Company's Commercial-APIs products include Acotiamide Hydrochloride Hydrate, Azelnidipine, Benfotiamine, Benidipine Hydrochloride, Citicoline Sodium, Gliclazide, Dapagliflozin Propanediol Monohydrate, Levosulpiride, Luliconazole, Oxaceprol, Prucalopride Succinate, Teneligliptin Hydrobromide Hydrate, Vildagliptin, Fimasartan Trihydrate Potassium, Obeticholic Acid, Ursodeoxycholic Acid and others. Its Commercial KSMs, Intermediates and Reagents products include Ethyl-2-Amino 1,3-Thiazole 4-Carboxylate; 2,4,5-Trimethoxy Benzoic Acid; Ethyl 2-(2,4,5-trimethoxybenzamido)-1,3-thiazole-4-carboxylate; Choline phosphate chloride calcium, and others.

KIMIA BIOSCIENCES LIMITED Financial Highlights

  • Revenue: KIMIA BIOSCIENCES LIMITED reported revenue of ₹116.50 crore in FY26 vs ₹120.24 crore in FY25. It showed a decrease of 3.11% on a yearly basis.
  • Operating Profit: KIMIA BIOSCIENCES LIMITED reported an operating profit of ₹8.46 crore in FY26 vs ₹13.63 crore in FY25. It showed a decrease of 37.93% on a year-on-year basis.
  • Net Profit: KIMIA BIOSCIENCES LIMITED reported a net profit of ₹7.43 crore in FY26 vs ₹9.61 crore in FY25. It showed a decrease of 22.68% on a yearly basis.

KIMIA BIOSCIENCES LIMITED Quarterly Result Highlights

  • KIMIA BIOSCIENCES LIMITED reported revenue of ₹20.80 crore in Jun 2026, compared with ₹28.21 crore in Mar 2026, representing a decrease of 26.27% on a quarter-on-quarter (QoQ) basis.
  • KIMIA BIOSCIENCES LIMITED reported an operating profit of ₹0.49 crore in Jun 2026, compared with ₹1.76 crore in Mar 2026, representing a decrease of 72.16% on a quarter-on-quarter (QoQ) basis.
  • KIMIA BIOSCIENCES LIMITED reported a profit of ₹0.36 crore in Jun 2026, compared with ₹0.37 crore in Mar 2026, reflecting a decrease of 2.70% on a QoQ basis.
  • The earnings per share (EPS) of KIMIA BIOSCIENCES LIMITED stood at ₹2.03 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
74.94%
FII
0.00%
Other DII
0.00%
Retail and other
24.68%
Mutual funds
0.38%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
130.63
P/E
18.16
P/B
7.37
ROE
41.95%
D/E
1.96
ROCE
22.81%
Div. Yield
0.00%
EPS(TTM)
1.64
Turnover
1.09
EV/EBITDA
11.02
Net Margin
0.00%
Op. Margin
0.00%
ROA
6.97%
Quick Ratio
0.00
Curr. Ratio
1.29
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Kimia Bioscien. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Kimia Bioscien. appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,41,958.0036.485.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,47,576.0084.6414.7715.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,233.0087.7722.5025.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,11,671.0024.324.1218.59%0.3117.35%237.300.09%0.3335.38
Cipla1,10,273.0032.863.2011.27%0.0014.95%423.360.95%0.4543.52
Laurus Labs1,06,460.0097.6420.0916.77%0.4016.14%97.200.10%0.6713.72
Dr. Reddy's Laboratories96,906.4030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Aurobindo Pharma96,401.7025.982.549.25%0.1911.76%394.820.24%0.3841.58
Lupin95,842.9017.274.2723.76%0.0424.88%659.000.86%0.57129.18
Mankind Pharma94,050.4045.495.7711.74%0.3413.13%396.980.04%0.4449.37

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

KIMIA BIOSCIENCES LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹118.92₹104.88₹128.52₹124.90
Other Income₹1.32₹1.64₹1.21₹0.93
Total Revenue₹120.24₹106.52₹129.73₹125.83
Total Expenses₹106.61₹113.70₹141.07₹130.85
Profit Before Tax₹13.63-₹7.18-₹12.39-₹5.02
Tax₹4.02-₹1.88-₹3.04-₹1.32
Profit After Tax₹9.61-₹5.31-₹9.35-₹3.70
EPS - Basic₹2.03-₹1.12-₹1.98-₹0.78
EPS - Diluted₹2.03-₹1.12-₹1.98-₹0.78

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹13.63-₹7.18-₹12.39-₹5.02
Income before WC changes₹20.46₹0.57-₹4.79₹0.94
Change in Assets-₹13.92₹21.35-₹10.14-₹4.08
Change in Liabilities₹14.72-₹7.41₹8.14₹11.21
Change in WC₹0.80₹13.94-₹2.00₹7.13
Cash flow from Operations₹21.31₹14.53-₹6.77₹8.00
Cash flow from Investing-₹4.70-₹1.49-₹2.80-₹0.71
Cash flow from Financing-₹16.55-₹13.07₹9.54-₹7.67
Total Cash Flow₹0.06-₹0.03-₹0.03-₹0.38
Cash (Start of the year)₹0.15₹0.18₹0.20₹0.59
Cash (End of the year)₹0.21₹0.15₹0.18₹0.20

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹35.92₹38.56₹38.57₹36.42
Current Assets₹75.29₹61.41₹82.75₹73.07
Total Assets₹111.21₹99.97₹121.32₹109.49
Current Liabilities₹81.83₹69.44₹76.40₹61.80
Net Current Asset-₹6.53-₹8.03₹6.35₹11.27
Non-Current Liabilities₹19.42₹30.20₹39.46₹32.80
Equity Capital₹9.97₹0.33₹5.46₹14.89
Total Equity & Liabilities₹111.21₹99.97₹121.32₹109.49
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
40.96
Neutral
ATR (14)
1.27
Neutral
STOCH(9,6)
43.84
Neutral
STOCH RSI (14)
25.43
Neutral
ADX(9)
27.56
Bearish
UO(9)
47.03
Neutral
ROC(12)
-1.04
Bearish
WillR(14)
-56.16
Neutral
Period
Simple value
Exponential vaue
5D
28.95
28.73
10D
29.03
28.8
20D
28.51
28.91
50D
30.15
29.94
100D
32.38
31.14
Volume trend — traded volume by day
11 Sep0L
10 Sep0L
9 Sep0L
8 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
KIMIA BIOSCIENCES LIMITED Share Price
KIMIA BIOSCIENCES LIMITED
Pharmaceuticals
Add Stock
Add Another

KIMIA BIOSCIENCES LIMITED Share Price FAQs

KIMIA BIOSCIENCES LIMITED share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837